NATIONAL RETIREES LEGISLATIVE NETWORK banner
buttons
NRLN Facebook Page Sign Up to Receive Important Messages
or Update Your Email Address
Contribute
to the NRLN
Write Personal Email
to Your Members of Congress
Respond
to an ACTION ALERT


WELCOME TO OUR COMMUNITY

crowd

 

If you did not receive an email with the NRLN President’s Forum message or an Action Alert posted on this home page, possibly you mistakenly “unsubscribed” on one of our emails or you have a new email address. You will no longer hear from us unless you “re-subscribe”. To "subscribe" or “re-subscribe”, click here.


NRLN presents PREPARING FOR MEDICARE ENROLLMENT 2019

for full screen viewing, click on below

Bill Kadereit, pres
PRESIDENT'S FORUM

(click here for previous FORUM articles )

NRLN President’s Forum: Drug Companies’ Payments to Doctors

If you have ever encountered a doctor writing a prescription for an expensive drug when a less expensive drug was available, the reason might be that the doctor was receiving money from the pharmaceutical company for promotional talks and consulting.

ProPublica, an independent, nonprofit newsroom that produces investigative journalism, found that roughly more than 600,000 doctors received payments from drugmakers and medical device companies in any given year 2014 - 2018. More than 2,500 physicians have received at least half a million dollars apiece in the past five years alone. More than 700 of those doctors received at least $1 million in the same period.

In 2013, ProPublica reported on an in depth investigation of the pharmaceutical industry’s drive to influence prescription writing. Six years later and such earnings by certain doctors have become commonplace despite scrutiny from prosecutors and academics.

Each year from 2014 to 2018, drug and medical device companies spent between $2.1 billion and $2.2 billion to pay doctors for speaking and consulting, as well as on meals, travel and gifts for them, ProPublica found. (These figures do not include research spending, but they do include royalties.)

Of the top 20 drugs with the most annual spending on doctors from 2014 to 2018, six made the list in each of the years: Invokana to treat type 2 diabetes; the blood thinners Xarelto and Eliquis; the antipsychotic Latuda; the immunosuppressive drug Humira, and the multiple sclerosis drug Aubagio. Another three drugs were on the list for four years: Victoza to treat type 2 diabetes; psoriasis treatment Otezla, and the cholesterol-lowering drug Repatha. Xarelto topped the list in spending for four years, totaling more than $123 million in payments from 2014 to 2018.

ProPublica noted there is a perception among many physicians, including some in academia, that drug company payments are fairly benign — a moonlighting gig that educates other doctors about important medications. But since ProPublica began looking at physician payments, one drugmaker after another has paid tens, or even hundreds, of millions of dollars to resolve allegations of improper, or illegal, marketing tactics.

Bill Kadereit, President
National Retiree Legislative Network

HOW YOU CAN HELP

  • SUBSCRIBE to receive periodic emails,
  • ACT on NRLN Action Alerts,
  • CONTRIBUTE to NRLN’s lobby effort, or
  • Make a tax-deductible DONATION to our American Retirees Education Foundation (AREF) research

 

PHARMA CONTRIBUTIONS TO CONGRESS -Early 2019-20 report

money How much did your U.S. Representatives and Senators take as campaign contributions from the Pharmaceutical and Health Products Industry for their recent election campaigns and the current 2019-20 one? Could this be a reason why bills to reduce the price of prescription drugs are not being passed? Click here to see data what the NRLN has compiled from OpenSecrets.Org, Center for Responsive Politics

 

amazon smile AmazonSmile Program to Benefit the American Retirees Education Program (AREF)

The NRLN board created the American Retiree Education Foundation (AREF) in 2014 as a 501(c)(3) tax-deductible, nonprofit education foundation to expand the research and educational reach of the NRLN and to enable NRLN to sharpen its focus as an organization lobbying for the passage of federal legislation and regulations that benefit retirees.

For example, the white paper on Protecting Pension Assets which is used to educate members of Congress on the need for legislation to prevent pension plan sponsors from using plan assets for non-pension expenses was funded by AREF.. Access the white paper here.

You can help fund the AREF without costing you anything extra when you make a purchase online from Amazon through its AmazonSmile program. Click here to learn more about AmazonSmile.

VIDEOS FROM THE RECENT FLY-IN

Comments made by NRLN leaders at the recent fly-in to Wash ington.

 

 

SOCIAL SECURITY COLA FOR 2020

The Social Security Administration announced on October 10 a 1.6% cost-of-living adjustment for 2020, meaning the average retiree will get $24 more each month. In 2019, the COLA was 2.8%, an increase of about $40 a month for retirees.

The increase in benefits applies to the 63 million Social Security beneficiaries and the 8 million Americans who get Supplementary Security Income benefits. In total, the change affects 69 million beneficiaries since some Americans receive both Social Security and SSI benefits. Social Security and SSI beneficiaries usually are notified by mail in early December about their new benefit amount.

The NRLN is lobbying for passage of the Social Security 2100 Act that would ensure the solvency of the program for the next 75 years. Enactment would also change the annual COLA from the current CPI-W index pegged to urban wage earners’ living expenses to CPI-E (Elderly) based on older Americans’ spending patterns, including high medical costs.

The maximum amount of earnings subject to the Social Security tax will increase about 3.6% next year to $137,700 from $132,900. Earners reaching that threshold will have to pay an additional $297 in taxes, as will their employers.

 

ACTION ALERT

Tell Congress to Pass the Stop STALLING Act

Passage of the Stop STALLING Act would reduce the incentives for branded pharmaceutical companies to introduce sham petitions to interfere with the regulatory approval of generics and biosimilars that would compete with their own prescription drugs. Click here to email the NRLN’s sample letter (https://www.nrln.org/SE.html#/) to ask your Representative and Senators to urge Speaker of the House Nancy Pelosi and Senate Majority Leader Mitch McConnell to bring the bill to a floor vote.

Adobe® Reader® is required to view some documents. Please download free copy by clicking here.

 

NRLN ANNOUNCES TWO NEW Webpages

There are now 11 chapters and 1 region webpages representing various constituencies or retired company employee groups.

Click here to access the webpage for the Lucent / Nokia Retirees Chapter which is being formed because the Lucent Retirees Organization has announced it will dissolve in 2020.

Click here to access the Pacific / Mountain West Region webpage which is a source for information for grassroots advocates particularly in Alaska, Hawaii, Idaho and Montana. Oregon, Utah and Washington Chapters have their own webpages.

 

NRLN members are saving big with the Free Health Savings Rx Card℠

The NRLN has arranged to offer you a Health Savings Rx Card™, at NO COST, that offers you and your family savings on prescription drugs, plus vision and hearing services and products.Click here to access the Rx Savings Card℠ website.

 

report card

NRLN Provides New “Report Card” Feature on Members of Congress

Do your Senators or Representative support bills that help retirees? Check it out here!

IN THE NEWS...

The articles and opinion pieces below are for information and are not necessarily a reflection of the NRLN’s position on issues. The NRLN is nonpartisan and its positions on retirement issues are presented in its Legislative Agenda and white papers that can be accessed from the Legislative Agenda tab.

Private equity-funded doctors coalition spends $4 million lobbying on 'surprise' medical billing
By Jessie Hellmann; The Hill ~ Oct 21, 2019

How GE Shafted Its Retirees
From John Mauldin; Forbes ~ Oct 21, 2019

Opinion: The Case Against Amalgam Fillings
By Dr. Nammy Patel; Forbes ~ Oct 21, 2019

Opinion: Social Security Expansion Hits Speed Bumps
From Andrew Biggs; Forbes ~ Oct 21, 2019

Supporting a patient-focused solution for surprise medical billing
From John Rother; The Hill ~ Oct 20, 2019

7 Changes to Social Security in 2020
By Sean Williams; The Motley Fool ~ Oct 20, 2019

Don’t Let Painful Joints Make You Sedentary
From Kristen Gerencher; The Hill ~ Oct 19, 2019

Are Your 2020 Social Security Taxes Going Up?
By Dan Caplinger; The Motley Fool ~ Oct 19, 2019

Opinion: CMS policy shouldn't penalize those with rare disease
From Josh Mailman; The Hill ~ Oct 18, 2019

Despite Intense Scrutiny, Doctors Still Receiving Astronomical Sums From Drug and Medical Device Companies
Via KHN Morning Briefing; Kaiser Health News ~ Oct 18, 2019

Medigap Plan F Will Soon End. Here’s How That Changes Retirees’ Costs.
By Gail MarksJarvis; Barron’s ~ Oct 18, 2019

In Pricing Plan, House Dems Bump Up Minimum Number Of Drugs To Be Negotiated In Effort To Woo Progressives
Via KHN Morning Briefing; Kaiser Health News ~ Oct 17, 2019

Opinion: Now Is The Time To Vote On Expanding Social Security
From Nancy Altman; Forbes ~ Oct 17, 2019

Pelosi moves on drug prices despite falling out with Trump
By Ricardo Alonso-Zaldivar; The Associated Press ~ Oct 17, 2019

Opinion: These Social Security plans could help solve America's retirement crisis
From Monique Morrissey; CNN Business ~ Oct 17, 2019

How to reform Social Security for future generations of Americans
From Jacob Lew, Henry Aaron, Kenneth Apfel &Robert Reischauer; The Hill ~ Oct 17, 2019

7 Republican senators urge passage of SECURE Act
By Brian Croce; Pensions & Investments ~ Oct 16, 2019

Senate Democrats turn up pressure for multiemployer reform
By Hazel Bradford Pensions & Investments ~ Oct 16, 2019

Report: Prescription Drug Prices Climb Nearly 26% in 3 Years
By Jennifer Nessel; Pharmacy Times ~ Oct 15, 2019

Legislation proposes new PBGC funding source from QPAM fees
By Hazel Bradford; Pensions & Investments ~ Oct 15, 2019

Caregivers Of Medicare Patients: What To Know Before A Hospital Discharge
From Donna Pols Trump, NA; Forbes ~ Oct 15, 2019

CBO says House Speaker Nancy Pelosi's drug pricing plan saves Medicare $345 billion over decade
By Berkeley Lovelace Jr, CNBC – Oct 14, 2019

California’s New Transparency Law Reveals Steep Rise In Wholesale Drug Prices
By Barbara Feder Ostrov & Harriet Blair Rowan; Kaiser Health News ~ Oct 14, 2019

GE joins corporate brethren in trend to put DB plan in the rearview mirror
By James Comtois; Pensions & Investments ~ Oct 14, 2019

Opinion: America's workers and small business owners need the SECURE Act
From John Carter; The Hill ~ Oct 14, 2019

Opinion: Caution for Democrats: Voters care more about drug pricing than impeaching Trump
From Douglas Schoen; The Hill ~ Oct 13, 2019

How Will The Medicare Part D Benefit Change Under Current Law and Leading Proposals?
By Juliette Cubanski & Tricia Neuman; Kaiser Family Foundation ~ Oct 11, 2019

Opinion: What Your Long Term Care Insurance Won't Cover And How To Prepare For It
From John E. Girouard; Forbes ~ Oct 14, 2019

Congress Takes Aim at a Social Security Benefit Killer
By Dan Caplinger; The Motley Fool ~ Oct 14, 2019

There’s a New Tax Form for Seniors. Here’s How to Use It.
By Daisy Maxey; Barron’s ~ Oct 12, 2019

CBO: Pelosi bill to lower drug prices saves Medicare $345 billion
By Peter Sullivan; The Hill ~ Oct 11, 2019

Congress must get pharma out of NAFTA 2.0
From Alex Lawson & Linda Benesch; The Hill ~ Oct 11, 2019

PhRMA CEO warns Pelosi bill to lower drug prices would be 'devastating' for industry
By Peter Sullivan; The Hill ~ Oct 10, 2019

Already in trouble, corporate pension plans are doomed by low interest rates
By Allison Schrager; Quartz ~ Oct 10, 2019

Social Security Is Letting Millennials Down
From John Mauldin; Forbes ~ Oct 10, 2019

Social Security’s 2020 Cost-of-Living Bump: 1.6%
By Nick Fortuna; Barron’s ~ Oct 10, 2019

Antiquated Medicare Fraud Rules Eyed for Overhaul
By Jack Rodgers; Courthouse News Service ~ Oct 09, 2019

Medicare Fraudsters Now Tap Telemedicine In Medical Equipment Scams
By Victoria Knight; Kaiser Health News ~ Oct 09, 2019

Shopping For Medicare? What To Know About The New Plan Finder
From Fred Riccardi, NA; Forbes ~ Oct 09, 2019

CMS Wants To Make It Easier For Consumers To Find Out If Nursing Homes Have Been Penalized For Abuse, Neglect
Via KHN Morning Briefing; Kaiser Health News ~ Oct 08, 2019

AT&T called out in ERISA suit over early retirement benefits
By Robert Steyer; Pensions & Investments ~ Oct 08, 2019

Drug price hikes cost US billions, report finds
By Nathaniel Weixel; The Hill ~ Oct 08, 2019

As Medicare Enrollment Nears, Popular Price Comparison Tool Is Missing
By Susan Jaffe; Kaiser Health News ~ Oct 08, 2019

4 reasons the corporate pension is on its deathbed
By Nathan Bomey; USA TODAY ~ Oct 07, 2019

Trump’s New Order For Medicare Packs Potential Rise In Patients’ Costs
By Julie Appleby; Kaiser Health News ~ Oct 07, 2019

GE to freeze, pre-pay pensions to save up to $8 billion, cut debt
By Alwyn Scott & Ankit Ajmera; Reuters ~ Oct 07, 2019

Column: The biggest bull market ever — yet disaster looms for millions of retirees
From Paul Brandus; MarketWatch ~ Oct 05, 2019

Will $1 million be enough in retirement? It depends
By Annie Nova; CNBC ~ Oct 04, 2019

Common Retiree Scams, and How to Avoid or Respond to Them
By Cheryl Winokur Munk; Barron’s ~ Oct 05, 2019

Trump administration Medicare official: Sanders and Warren's 'socialist experiments' won't work for seniors
By Julia Musto; Fox News ~ Oct 04, 2019

Humana's chief strategy officer: Insurance giant is shifting to be a healthcare company
By Heather Landi; FierceHealthcare ~ Oct 03, 2019

Financial Scams Targeting the Elderly Are Rising. Advisors Offer Precautions.
By Steve Garmhausen; Barron’s ~ Oct 03, 2019

New Medicare rule is a step forward on price transparency, but more is needed
From George A. Nation III; The Hill ~ Oct 03, 2019

Few employers ‘very confident’ in workers’ retirement security – survey
By Rob Kozlowski; Pensions & Investments ~ Oct 03, 2019

Is Congress too afraid to fight Big Pharma?
From Dr. Sanjeev Sriram; The Hill ~ Oct 04, 2019

Medicare Shopping Season Is Almost Here
By Mark Miller; The New York Times ~ Oct 04, 2019

Trump attacks 'Medicare for All' in Florida, accuses Dems of wanting to fund 'socialism'
By Peter Sullivan; The Hill ~ Oct 03, 2019

Trump cites his support for Medicare, slams Medicare for All
By Kevin Freking & Ricardo Alonso-Zaldivar; The Associated Press ~ Oct 03, 2019

What Trump’s Executive Order Means for Healthcare
By Andrew Hirschfeld; Fortune ~ Oct 03, 2019

Urging Doctors and Health Systems To Recognize The Importance Of Social Supports To Patients
From Howard Gleckman; Forbes ~ Oct 02, 2019

Commentary: Americans Spent More on Taxes in 2018 Than on Food, Clothing and Health Care Combined
From Terence P. Jeffrey; CNS News ~ Oct 02, 2019

Opinion: Pelosi's prescription drug 'negotiations' would harm Americans and benefit China, Russia
From Kent Kaiser; The Hill ~ Oct 01, 2019

New Round of Medicare Readmission Penalties Hits 2,583 Hospitals
By Jordan Rau; Kaiser Health News ~ Oct 01, 2019

Medicare’s ACO Program, Which Offers Doctors, Hospitals Rewards For Better Care, Saved $740M Last Year
Via KHN Morning Briefing; Kaiser Health News ~ Oct 01, 2019

Trump and Pelosi aides talk drug costs despite impeachment
By Ricardo Alonso-Zaldivar; The Associated Press ~ Oct 01, 2019

CVS halts sales of heartburn drug Zantac over cancer concerns
By Peter Sullivan; The Hill ~ Sep 30, 2019

Trump Administration Health Transparency Policy Triggering Industry Sparks
Via KHN Morning Briefing; Kaiser Health News ~ Sep 30, 2019

Time To Talk About Healthcare Total Cost Of Ownership
From Erik Sherman; Forbes ~ Sep 29, 2019

Can Washington deliver on drug costs amid impeachment probe?
By Ricardo Alonso-Zaldivar; The Associated Press ~ Sep 29, 2019

Enrolling in a Medicare prescription drug plan? You'll need extra time, advocates say
By Kristen Jordan Shamus; Detroit Free Press ~ Sep 29, 2019

Trump to give health care speech in Florida next week
By Peter Sullivan; The Hill ~ Sep 28, 2019

4 costly scams targeting older people that you should know about — but probably don’t
By Catey Hill; MarketWatch ~ Sep 28, 2019

The Worrisome Social Security Trend Few People Know About
By Sean Williams; The Motley Fool ~ Sep 28, 2019

It's time to axe the unjust 'widow's tax'
From Rep. Joe Wilson (R-S.C.); The Hill ~ Sep 27, 2019

Cost Is The Issue
From Grace-Marie Turner; Forbes ~ Sep 27, 2019

A Wall Street tax can help pay for bold policy solutions
From Susan Harley; The Hill ~ Sep 27, 2019

Feds crack Medicare gene test fraud that peddled cheek swabs
By Ricardo Alonso-Zaldivar; The Associated Press ~ Sep 27, 2019

KHN Files Lawsuit To Force Feds To Disclose Medicare Advantage Audits
By Fred Schulte; Kaiser Health News ~ Sep 27, 2019

How Arbitration For Surprise Medical Bills Leads To Runaway Costs & Higher Premiums
By Avik Roy ; Forbes ~ Sep 27, 2019

As Health Care Costs Rise, Workers At Low-Wage Firms May Pay A Larger Share
By Michelle Andrews; Kaiser Health News ~ Sep 25, 2019

The 2020 Social Security COLA is expected to be low — and that’s not even the worst part
By Alessandra Malito; MarketWatch ~ Sep 26, 2019

House Republicans Rebel Against Pelosi’s Drug Plan While Senators Release Bipartisan Bill
Via KHN Morning Briefing; Kaiser Health News ~ Sep 26, 2019

How retirees can check if they're having enough taxes withheld
By Susan Tompor; Detroit Free Press ~ Sep 25, 2019

New frontier in health fraud: Genetic tests of the elderly
By Sarah N. Lynch; Reuters ~ Sep 25, 2019

Impeachment push threatens to derail bipartisan efforts on health care costs
By Jessie Hellmann; The Hill ~ Sep 25, 2019

3 New Retirement Rules That May Change Retirement As We Know It
By Jackie Campbell; Forbes ~ Sep 25, 2019

CBO: Fix backed by doctors for surprise medical bills would cost billions
By Peter Sullivan; The Hill ~ Sep 24, 2019

2 Democratic lawmakers ask EBSA to delay upcoming reorganization
By Brian Croce; Pensions & Investments ~ Sep 23, 2019

Aggressive Lobbying Effort Creating A Drag On Legislative Momentum Behind Surprise Medical Bills
Via KHN Morning Briefing; Kaiser Health News ~ Sep 23, 2019

Warning: You Can Be Taxed Higher In Retirement -- How To Stop That
From Larry Light; Forbes ~ Sep 23, 2019

Drugmakers, Facing ‘Stiffest Political Headwinds,’ Mount Strong Lobbying Effort In Congress
Via KHN Morning Briefing; Kaiser Health News ~ Sep 24, 2019

Drug prices for seniors once again rose faster than inflation, report says
By Jen Christensen; CNN ~ Sep 23, 2019

Opinion: Elizabeth Warren, Bernie Sanders, Capitalism, And Retirement Accounts: The Dog That Didn’t Bark
From Elizabeth Bauer; Forbes ~ Sep 22, 2019

Opinion: Pelosi’s Destructive Drug Ploy
From Grace-Marie Turner; Forbes ~ Sep 20, 2019

Need Cash? Hardship Withdrawals From Your Retirement Plan Just Got Easier
By Ashlea Ebeling; Forbes ~ Sep 20, 2019

Older Americans Are Starting More Businesses Than Ever
By Chris Farrell; Bloomberg ~ Sep 20, 2019

Pelosi offers Medicare negotiation plan to curb drug prices
By Ricardo Alonso-Zaldivar; The Associated Press ~ Sep 19, 2019

3 things NOT to do with your savings now that the Fed has cut interest rates
By Jacob Passy; MarketWatch ~ Sep 19, 2019

Seniors will soon have their own IRS tax form
By Ed Leefeldt; CBS News ~ Sep 19, 2019

What You Need To Know About Inheriting An IRA
From David Rae; Forbes ~ Sep 19, 2019

Judge Sides With Hospitals Over Medicare Payments For Clinic Visits
Via KHN Morning Briefing; Kaiser Health News ~ Sep 18, 2019

3 Facts Most People Get Wrong About Social Security
By Katie Brockman; The Motley Fool ~ Sep 15, 2019

Is The New Medicare Plan Finder Putting Seniors In Jeopardy?
From Diane Omdahl; Forbes ~ Sep 18, 2019

House To Probe Private Equity Firms’ Stakes In The Debate Over Surprise Medical Bills
Via KHN Morning Briefing; Kaiser Health News ~ Sep 17, 2019

U.S. Senators urge FTC to scrutinize multi-billion dollar pharma mergers
By Saumya Sibi Joseph; Reuters ~ Sep 17, 2019

Opinion: Primary Care Is Integral To Improving U.S. Healthcare, But Is Falling Further Behind
From Joshua Cohen; Forbes ~ Sep 16, 2019

How to Avoid Financial Deadlock—or Worse—After One Spouse Dies
By Cheryl Winokur Munk; Barron’s ~ Sep 15, 2019

Opinion: Study Finds Dementia Patients Need More Home-Based Medical Care
From Debbie Musser, NA; Forbes ~ Sep 16, 2019

Opinion: Obamacare Drives Hospital Consolidation, Raising Prices For Patients
From Sally Pipes; Forbes ~ Sep 16, 2019

Stakes Are High As Congress Aims To Tackle Array Of Health Issues Before End Of The Year
Via KHN Morning Briefing; Kaiser Health News ~ Sep 16, 2019

Opinion: Saving surprise medical billing legislation
From George A. Nation III; The Hill ~ Sep 16, 2019

HHS wants to give you your health data — do you want it?
By Mohana Ravindranath; Politico ~ Sep 16, 2019

Opinion: How to make your retirement savings last forever
From Mark Hulbert; MarketWatch ~ Sep 15, 2019

Opinion: The promise and peril of offshoring prescription drug pricing
From Andrew Mulcahy; The Hill ~ Sep 14, 2019

The New Medicare Plan Finder Doesn’t Make Finding Your Best Drug Coverage Easy
From Diane Omdahl; Forbes ~ Sep 14, 2019

The 'advancing American kidney health' initiative lives up to its name
From Kevin Longino & Tod Ibrahim; The Hill ~ Sep 13, 2019

Opinion: We Have The Road Map To The President’s Health Plan
From Grace-Marie Turner; Forbes ~ Sep 13, 2019

2 pension funds petition MPRA for benefit reductions
By Hazel Bradford; Pensions & Investments ~ Sep 13, 2019

Why Do We Still Have U.S. Mail And How Much Longer Will We Have It?
From Blake Morgan; Forbes ~ Sep 13, 2019

FDA warns of contaminant in popular heartburn medicine
By Nathaniel Weixel ; The Hill ~ Sep 13, 2019

Health groups backed dark money campaign to sink 'surprise' billing fix
By Rachel Roubein; Politico ~ Sep 13, 2019

Here's What We Know About How Drugs Are Priced — And What We Don't
Investor’s Business Daily ~ Sep 12, 2019

Opinion: 9 Things You Need To Know About Power Of Attorney
From Christine Fletcher; Forbes ~ Sep 12, 2019

Your Social Security checks could get bigger next year. Here’s how much
By Lorie Konish; CNBC ~ Sep 12, 2019

Proposed financial transaction taxes would hit U.S. pension funds – report
By Rob Kozlowski; Pensions & Investments ~ Sep 11, 2019

Investors’ Deep-Pocket Push To Defend Surprise Medical Bills
By Rachel Bluth & Emmarie Huetteman; Kaiser Health News ~ Sep 11, 2019

How To Correct This Big Medicare Mistake
From Steve Vernon; Forbes ~ Sep 11, 2019

Opinion: How To Find A Good Estate Planner
By Elizabeth Alterman, NA; Forbes ~ Sep 11, 2019

Ahead of election year, more Americans lack health insurance, incomes stall
By Lindsay Dunsmuir & Howard Schneider; Reuters ~ Sep 10, 2019

Drug Prices Keep Rising Amid Political Pressure, But Not As Fast
By Leah Rosenbaum; Forbes ~ Sep 10, 2019

Opinion: Medicare Advantage Coverage Rules For PPOs Appear To Have Vanished From The New Plan Finder
From Diane Omdahl; Forbes ~ Sep 10, 2019

Opinion: Where There's A Will, There's Not Always An Estate Plan
From Jamie Hopkins; Forbes ~ Sep 10, 2019

Beyond Gun Control: Prescription Drug Prices, Surprise Medical Bills Are At Top Of Congress’ Health Agenda For Fall
Via KHN Morning Briefing; Kaiser Health News ~ Sep 09, 2019

Pelosi draft plan would allow negotiation on 250 drugs per year: summary
By Peter Sullivan; The Hill ~ Sep 09, 2019

Washington risks seeing bipartisan victories on healthcare slip out of reach this fall
By Kimberly Leonard; The Washington Examiner ~ Sep 09, 2019

What Medicare for All would mean for the 60 million people already on Medicare
By Tami Luhby; CNN ~ Sep 08, 2019

Opinion: Rising retiree bankruptcies? It's a myth
From Andrew Biggs; The Washington Examiner ~ Sep 06, 2019

Are insurance companies driving doctors out of the profession?
From Elizabeth O’Connor; The Hill ~ Sep 07, 2019

Senate to start work on funding bills with shutdown deadline looming
By Jordain Carney; The Hill ~ Sep 06, 2019

Groupons For Medical Treatment? Welcome To Today’s U.S. Health Care
By Lauren Weber; Kaiser Health News ~ Sep 06, 2019

Democratic Support For Medicare For All In The House Just Crossed A Major Hurdle
By Andrew Kerr; The Daily Caller ~ Sep 06, 2019

Avoiding The Long-Term-Care Catastrophe
From William A. Haseltine; Forbes ~ Sep 06, 2019

Ernst calls for Congress to fix Social Security 'behind closed doors'
By Rachel Frazin ; The Hill ~ Sep 05, 2019

Analysis: How Your Beloved Hospital Helps To Drive Up Health Care Costs
By Elisabeth Rosenthal; Kaiser Health News ~ Sep 05, 2019

The American Medical System Is One Giant Workaround
From Theresa Brown; The New York Times ~ Sep 05, 2019

Medicare Advantage home healthcare may not be best quality
By Lisa Rapaport; Reuters ~ Sep 05, 2019

Push on 'surprise' medical bills hits new roadblocks
By Peter Sullivan; The Hill ~ Sep 05, 2019

Trump Promises ‘Phenomenal’ Health Plan. What Might That Mean?
By Julie Appleby; Kaiser Health News ~ Sep 04, 2019

Opinion: Socialism won’t fix drug prices: Stacy Washington
From Stacy Washington; Post & Journal ~ Sep 04, 2019

Is The New Medicare Plan Finder A Barrier Against Open Enrollment Plan Review?
From Diane Omdahl; Forbes ~ Sep 04, 2019

Fraud Alert: Genetic Testing Scam
By U.S. Department of Health and Human Services

Heidi Heitkamp: Protect pensions now for millions of Americans
From Heidi Heitkamp; CNBC ~ Sep 03, 2019

The war over Medicare Advantage audits heats up
By Bob Herman; Axios ~ Sep 03, 2019

Walmart Could Disrupt Health Care the Same Way It Did Retail, Analyst Says
By Josh Nathan-Kazis; Barron’s ~ Sep 03, 2019

Opinion: That Beloved Hospital? It’s Driving Up Health Care Costs
From Elisabeth Rosenthal; The New York Times ~ Sep 02, 2019

Protect Yourself From Healthcare Rip-Offs
From Kevin Loria; Consumer Reports ~ Sep 02, 2019